Vedolizumab treatment outcomes in early versus late Crohn's disease – Authors' reply

The Lancet. Gastroenterology & hepatology 2026

View at publisher

Authors: Geert D’Haens, Lotte Oldenburg, Melanie S. Hulshoff

DOI: 10.1016/s2468-1253(26)00013-0

Cited by: 0

References: 5

Fields of Study & Subjects

Inflammatory Bowel Disease Rheumatoid Arthritis Research and Therapies Ocular Diseases and Behçet’s Syndrome

References 5